April 20, 2018 12:31 PM ET


Company Overview of Nohla Therapeutics Inc.

Company Overview

Nohla Therapeutics Inc. develops and manufactures ex vivo expanded universal donor cellular therapies to treat patients with cancer and other life threatening illnesses. Its universal donor product is used to treat hematopoietic recovery, chemotherapy induced neutropenia, and other medical indications. The company was founded in 2015 and is based in Seattle, Washington.

1616 Eastlake Avenue East

Suite 202

Seattle, WA 98102

United States

Founded in 2015



Key Executives for Nohla Therapeutics Inc.

Chief Executive Officer, President and Executive Director
Founder, Chief Medical Officer and Member of Scientific Advisory Board & Clinical Advisory Board
Chief Financial Officer
Age: 73
Chair of Scientific Advisory Board, Chair of Clinical Advisory Board and EVP of Research & Mfg
Senior Director of Corporate Development & Investor Relations
Compensation as of Fiscal Year 2017.

Nohla Therapeutics Inc. Key Developments

Nohla Therapeutics Inc. Announces Initiation of its Phase 2 LAUNCH Clinical Trial

Nohla Therapeutics Inc. (Nohla) announced the initiation of its Phase 2 LAUNCH clinical trial. The open-label, multi-center, randomized, controlled, dose-finding LAUNCH trial will evaluate Nohla’s lead product candidate, NLA101, in adult patients with acute myeloid leukemia (AML) who are at risk for myelosuppression after receiving high-dose chemotherapy. The LAUNCH trial (NCT03301597) will enroll approximately 220 adult patients and will evaluate NLA101’s ability to reduce the rate of = Grade 3 infections associated with chemotherapy-induced neutropenia, and identify the lowest effective cell dose of NLA101. Patients in the Phase 2 study will be randomized to one of three investigational treatment arms or a control arm. Patients randomized to an investigational treatment arm will be eligible to receive a single fixed dose of NLA101 after the first cycle of chemotherapy, and up to two additional identical NLA101 doses after subsequent cycles of chemotherapy.

Nohla Therapeutics Inc. Presents at Phacilitate – Cell & Gene Therapy World, Jan-22-2018 through Jan-25-2018

Nohla Therapeutics Inc. Presents at Phacilitate – Cell & Gene Therapy World, Jan-22-2018 through Jan-25-2018. Venue: Hyatt Regency, Miami, Florida, United States. Presentation Date & Speakers: Jan-23-2018, Anna Gilbert, Director, Quality Assurance. Jan-24-2018, Anna Gilbert, Director, Quality Assurance. Jan-25-2018, Colleen Delaney, Founder, Chief Medical Officer and Member of Scientific Advisory Board & Clinical Advisory Board.

Nohla Therapeutics Inc. Appoints Jim Johnson as Chief Financial Officer

Nohla Therapeutics Inc. (Nohla) announced the appointment of James (Jim) Johnson as the company's new Chief Financial Officer (CFO). Mr. Johnson joins Nohla after serving for five years as the CFO of NanoString Technologies. During his tenure as CFO at NanoString, Mr. Johnson oversaw strategic and corporate finance activities from private stage through the company's initial public offering and additional rounds of financing, marking the third IPO in his career as a CFO.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

June 21, 2017

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Nohla Therapeutics Inc., please visit nohlatherapeutics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.